(Q33694959)

English

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

13

object named as

John M Kane

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Christoph Correll

14

object named as

Christoph U Correll

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Julie B Penzner

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Melissa Dudas

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ema Saito

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Vladimir Olshanskiy

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Umesh H Parikh

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sandeep Kapoor

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Raja Chekuri

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dominick Gadaleta

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jennifer Avedon

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Eva M Sheridan

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jane Randell

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Anil K Malhotra

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Child and Adolescent Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

563-573

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Prevention of bipolar disorder in at-risk children: Theoretical assumptions and empirical foundations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Effect of stimulants on height and weight: a review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Pharmacotherapy of aggression in children and adolescents: efficacy and effect size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Early identification and high-risk strategies for bipolar disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Child psychiatric disorders among primary mental health service attenders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Oppositional defiant and conduct disorder: a review of the past 10 years, part I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Treatment of clozapine sedation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

A children's global assessment scale (CGAS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

21 June 2018

Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Prolactin levels during long-term risperidone treatment in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Three Case Reports of Modafinil Use in Treating Sedation Induced by Antipsychotic Medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Epidemiology of psychiatric disability in childhood and adolescence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2830212

30 October 2018

Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19877981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/19877981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of ADHD and comorbid disorders among elementary school children screened for disruptive behavior

1 reference

https://pubmed.ncbi.nlm.nih.gov/19877981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19877981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate for clozapine sedation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19877981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1089/CAP.2009.0051

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33694959&oldid=1540050849"